‘Ozempic 2.0’: Major New Trial Findings Unveiled

An oral GLP-1 medication, similar in function to Ozempic, is approaching approval by the FDA. Developed by the American pharmaceutical firm Eli Lilly, the pill, named orforglipron, is in line with the company’s injectable offerings, Mounjaro and Zepbound. While medications…